UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-26 | Future report Set alerts | |
| Q2 2022 | 2022-07-28 | 0.16 | 0.16 |
| Q1 2022 | 2022-04-28 | 0.27 | 0.27 |
| Q4 2021 | 2022-02-24 | 0.28 | 0.28 |
| Q3 2021 | 2021-10-28 | 0.30 | 0.30 |
| Q2 2021 | 2021-07-29 | 0.40 | 0.40 |
| Q1 2021 | 2021-04-29 | 0.28 | 0.28 |
| Q4 2020 | 2021-02-25 | 0.34 | 0.34 |
| Q3 2020 | 2020-10-29 | 0.37 | 0.37 |
| Q2 2020 | 2020-07-23 | 0.17 | 0.17 |
| 2016-05-03 | Reiterated Rating | Brean Capital | Buy | |
| 2016-05-03 | Reiterated Rating | Canaccord Genuity | Buy | $6.00 to $18.00 |
| 2016-05-03 | Boost Price Target | Roth Capital | Buy | $18.00 to $18.50 |
| 2016-02-27 | Reiterated Rating | Barrington Research | Buy | |
| 2016-02-25 | Reiterated Rating | Roth Capital | Buy | |
| 2016-02-25 | Boost Price Target | Barrington Research | Outperform | $14.00 to $15.50 |
| 2016-02-25 | Reiterated Rating | Canaccord Genuity | Buy | $18.50 to $16.00 |
| 2016-02-08 | Upgrade | Sidoti | Neutral to Buy | $17.00 |
| 2016-01-20 | Initiated Coverage | Sidoti | Neutral | |
| 2015-12-16 | Reiterated Rating | Roth Capital | Buy | |
| 2015-12-07 | Boost Price Target | Dougherty & Co | Buy | $16.00 to $19.00 |
| 2015-12-07 | Boost Price Target | Roth Capital | Buy | $15.00 to $18.00 |
| 2015-12-04 | Reiterated Rating | Brean Capital | Buy | $15.00 to $17.50 |
| 2015-12-04 | Boost Price Target | Benchmark Co. | $15.00 to $18.00 | |
| 2015-12-04 | Reiterated Rating | Canaccord Genuity | Buy | $16.50 to $18.50 |
| 2015-12-04 | Boost Price Target | Stifel Nicolaus | Buy | $14.00 to $17.00 |
| 2015-10-28 | Reiterated Rating | Canaccord Genuity | Buy | $14.50 to $16.50 |
| 2015-10-28 | Boost Price Target | Brean Capital | Buy | $13.00 to $15.00 |
| 2015-10-28 | Boost Price Target | Benchmark Co. | $14.00 to $15.00 | |
| 2015-10-28 | Upgrade | Barrington Research | Market Perform to Outperform | $14.00 |
| 2015-09-10 | Initiated Coverage | Barrington Research | Market Perform | |
| 2015-07-30 | Reiterated Rating | Canaccord Genuity | Buy | $14.50 |
| 2015-07-29 | Boost Price Target | Benchmark Co. | Buy | $12.00 to $14.00 |
| 2015-07-29 | Boost Price Target | Brean Capital | Buy | $11.00 to $13.00 |
| 2015-07-29 | Boost Price Target | Roth Capital | Buy | $11.00 to $14.00 |
| 2015-06-19 | Initiated Coverage | Dougherty & Co | Buy to Buy | $14.00 |
| 2015-05-05 | Reiterated Rating | Roth Capital | Buy | $10.00 to $11.00 |
| 2015-04-30 | Reiterated Rating | Brean Capital | Buy | $11.00 |
| 2015-04-29 | Boost Price Target | Canaccord Genuity | Buy | $12.00 to $13.00 |
| 2015-03-01 | Reiterated Rating | Canaccord Genuity | Buy | $12.00 |
| 2015-02-26 | Reiterated Rating | Brean Capital | Buy | $11.00 |
| 2015-02-02 | Downgrade | Sidoti | Buy to Neutral | |
| 2014-10-29 | Reiterated Rating | Canaccord Genuity | Buy | $11.50 to $12.00 |
| 2014-06-24 | Initiated | Stifel | Buy | $11 |
| 2014-06-24 | Initiated Coverage | Stifel Nicolaus | Buy | $11.00 |
| 2014-05-19 | Initiated Coverage | Brean Capital | Buy | $11.00 |
| 2014-05-19 | Initiated Coverage | ING Group | Buy | $11.00 |
| 2013-11-13 | Boost Price Target | Benchmark Co. | Buy | $10.00 to $11.00 |
| 2013-10-30 | Boost Price Target | Canaccord Genuity | Buy | $10.50 to $11.50 |
| 2013-10-24 | Initiated Coverage | Benchmark Co. | Buy | $9.00 |
| 2013-10-10 | Initiated Coverage | Roth Capital | Buy | $10.00 |
| 2012-11-02 | Initiated | Barrington Research | Outperform | $7.50 |
| 2007-12-06 | Initiated | Jesup & Lamont | Buy | $10.50 |
| 2016-05-03 | Reiterated Rating | Brean Capital | Buy | |
| 2016-05-03 | Reiterated Rating | Canaccord Genuity | Buy | $6.00 to $18.00 |
| 2016-05-03 | Boost Price Target | Roth Capital | Buy | $18.00 to $18.50 |
| 2016-02-27 | Reiterated Rating | Barrington Research | Buy | |
| 2016-02-25 | Reiterated Rating | Roth Capital | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In LMAT 154 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 3.27M |
| Conestoga Capital Advisors, LLC | 1.85M |
| Vanguard Group, Inc | 1.44M |
| Copeland Capital Management, LLC | 1.22M |
| Ranger Investment Management, L.P. | 0.92M |
| GENEVA CAPITAL MANAGEMENT LLC | 0.89M |
| STATE STREET CORP | 0.71M |
| DIMENSIONAL FUND ADVISORS LP | 0.67M |
| BlackRock Institutional Trust Company, N.A. | 0.57M |
| BlackRock Fund Advisors | 0.44M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.39M |
| VOYA INVESTMENT MANAGEMENT LLC | 0.39M |
| AMERIPRISE FINANCIAL INC | 0.28M |
| PIONEER INVESTMENT MANAGEMENT INC | 0.28M |
| NORTHERN TRUST CORP | 0.28M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| LeMaitre George W Chairman and CEO | 18.27% (3165709) | LMAT / |
| LeMaitre Cornelia W V.P., Human Resources,Director | 1.06% (183319) | LMAT / |
| Pellegrino Joseph P JR Chief Financial Officer | 0.67% (116525) | LMAT / |
| O'Connor John James | 0.42% (72710) | LMAT / |
| Kamke Trent G Senior V. P., Operations | 0.19% (32792) | LMAT / |
| Roberts David B President and Director | 0.15% (26632) | LMAT / |
| Gebauer Peter R President, International OP | 0.05% (8477) | LMAT / |
| Jasinski Lawrence J | 0.05% (8333) | LMAT / RWLK / |
| Linden Robert V Senior VP Sales, The Americas | 0.03% (5736) | LMAT / |
| Wijas Michael T VP of Sales, The Americas | 0.02% (3584) | LMAT / |
UM